SCHEMBL12957930

SCHEMBL12957930

C=N/C=C(C)\C=N/C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19062429 0.72
SCHEMBL24086718 0.72
SCHEMBL21427869 0.72
SCHEMBL14042505 0.71
SCHEMBL10187591 0.70
SCHEMBL19661180 0.70
SCHEMBL8007666 0.69
SCHEMBL8173264 0.69
SCHEMBL16664150 0.69
SCHEMBL25160922 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072822-A2 DISPERSING AND WETTING AGENTS AND COMPOSITIONS AND METHODS OF USE THEREOF MOJAVE BIO, INC. (US) 2024-04-04 WO disclosed
US-20230365605-A1 BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-11-16 US disclosed
WO-2023154310-A1 2-METHYL-4-PHENYLPIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed
US-11672788-B2 Histone deacetylase inhibitors for immunomodulation in tumor microenvironment Great Novel Therapeutics Biotech & Medicals Corporation (TW) 2023-06-13 US disclosed
EP-4174059-A1 INDAZOLE-FUSED CYCLIC COMPOUND Medshine Discovery Inc. (CN) 2023-05-03 EP disclosed
WO-2022159454-A1 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE OF MEDICINE (US) 2022-07-28 WO disclosed
EP-3083569-B1 BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT AGENEBIO INC (US) 2022-01-26 EP disclosed
WO-2022013293-A1 HERBICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2022-01-20 WO disclosed
WO-2022001971-A1 INDAZOLE-FUSED CYCLIC COMPOUND 南京明德新药研发有限公司 2022-01-06 WO disclosed
EP-3590929-B1 SPIRO COMPOUND AND USE THEREOF MEDSHINE DISCOVERY INC (CN) 2021-09-15 EP disclosed
US-20180057492-A1 SPECIFIC N AND P ACTIVE MATERIALS FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES SONY CORPORATION (JP) 2018-03-01 US disclosed
US-9831445-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-28 US disclosed
US-20170327495-A1 PESTICIDALLY ACTIVE AMIDE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2017-11-16 US disclosed
EP-3097103-B1 DIAZABICYCLO[4.3.1]DECANE DERIVATIVES FOR TREATMENT OF PSYCHIATRIC DISORDERS MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS (DE) 2017-11-15 EP disclosed
US-9809587-B2 Pesticidally active heterocyclic derivatives with sulphur containing substituents SYNGENTA PARTICIPATIONS AG (CH) 2017-11-07 US disclosed
US-20170267672-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2017-09-21 US disclosed
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
EP-2269993-A1 2-AMINOQUINAZOLINE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2011-01-05 EP disclosed
WO-2009131173-A1 2-AMINOQUINAZOLINE DERIVATIVE 協和発酵キリン株式会社 (JP) 2009-10-29 WO disclosed
EP-1875912-A1 AGENT FOR TREATING INVOLUNTARY MOVEMENT Eisai R&D Management Co., Ltd. (JP) 2008-01-09 EP disclosed